Clinical trial
Markers for Chronic Obstructive Pulmonary Disease (COPD)
NCT00180622 · Imperial College London, Other · Withdrawn
Key facts
| NCT number | NCT00180622 |
|---|---|
| Title | Markers for Chronic Obstructive Pulmonary Disease (COPD) |
| Official title | Non-Invasive Markers for Chronic Obstructive Pulmonary Disease (COPD) |
| Lead sponsor | Imperial College London, Other |
| Collaborators | AstraZeneca Industry |
| Status | Withdrawn |
| Study type | Observational |
| Conditions | Healthy Non-smokers, Current Smokers, COPD Patients |
| Intervention type | Procedure |
| Interventions | Spirometry, Exhaled Nitric Oxide and Carbon Monoxide, Exhaled Breath Condensate, Induced Sputum, CT Scan, Blood test, St Georges Questionnaire, Bodypletysmography |
| Enrollment | 0 |
| Start date | Jul 1, 2001 |
| Primary completion | Jul 1, 2002 |
| Completion | Jul 1, 2002 |
| First posted | Sep 16, 2005 |
| Last update posted | Jul 5, 2019 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: